NCT04490993 2022-02-22
ACCRUE
Jiangsu Yahong Meditech Co., Ltd aka Asieris
Phase 3 Unknown
Clinical Trials
6 trialsNCT04736394 2022-02-22
ASCERTAIN
Jiangsu Yahong Meditech Co., Ltd aka Asieris
Phase 3 Unknown
NCT05146635 2022-01-11
Optimal Adjuvant Intravesical Therapy for Intermediate Risk Non Muscle Invasive Bladder Cancer: A Randomized Controlled Trial
Mansoura University
Phase NA Unknown
NCT02547350 2015-09-11
Prophylactic Intravesical Chemotherapy to Prevent Bladder Tumors After Nephroureterectomy for Primary Upper Urinary Tract Urothelial Carcinomas
Peking University First Hospital
Phase 2 Unknown
NCT01094964 2013-08-12
Hyperthermia and Mitomycin C, Bacillus Calmette-Guerin, or Standard Therapy as Second-Line Therapy in Treating Patients With Recurrent Bladder Cancer
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00218205 2005-09-22
A Study of Epirubicin With Estramustine Phosphate and Celecoxib for the Treatment of Prostate Cancer
Department of Veterans Affairs, New Jersey
Phase 2 Unknown